CurrentBlue Cross Blue Shield - KansasPolicy N/A

Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency-Coblation (Nucleoplasty)

This policy governs coverage for laser discectomy and disc nucleoplasty (radiofrequency coblation) for patients with discogenic low back pain or radiculopathy for members of Blue Cross and Blue Shield of Kansas.

Policy Summary

PayerBlue Cross Blue Shield - Kansas

PolicyDecompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency-Coblation (Nucleoplasty)

Policy CodePolicy N/A

Change TypeNo material change

Effective DateFebruary 8, 2010

Next Review DateN/A

Key ActionVerify member benefits with BCBSKS Customer Service prior to service to confirm coverage under the member's contract.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2004-10-18Original effective

2023-06-13Latest review

510(k)FDA pathway

1275Largest case series

90RCT patients (Gerszten)

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determination and Evidence

Coverage determination

Covered when ALL of the following are met

Policy Coverage Stance: Laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered experimental/investigational as techniques of disc decompression and treatment of associated pain.

Refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage.

Laser discectomy — evidence limitations

Evidence summary for laser discectomy

Observational evidence only: Available evidence for laser discectomy consists primarily of observational studies and case series; randomized controlled trial data are lacking or limited.

Observational studies are insufficient to permit conclusions concerning effects on health outcomes due to variable natural history and potential placebo effects.

Selected observational findings: Large case series and retrospective comparative reviews report variable success rates (examples: Choy 2004 series of 1,275 patients with 89% success by Macnab criteria; Menchetti et al reported 68% success at mean 5 years) but quantitative comparative data and statistical analyses are limited or not provided.

Comparative retrospective reviews lacked statistical comparisons; case series subject to selection and reporting bias.

Disc nucleoplasty — evidence and limitations

Evidence summary for disc nucleoplasty (radiofrequency coblation)

RCT evidence exists but limited: Randomized trials (Gerszten et al. 2010; Chitragran et al. 2012; de Rooij et al. 2020) have been conducted with mixed results; some RCTs show short-term benefits versus controls but limitations include unblinded design, industry sponsorship, small sample sizes, discontinued or underpowered enrollment, and variable long-term outcomes.

Secondary procedure rates and long-term outcomes varied across trials; interpret results cautiously due to methodological limitations.

Key trial findings: Gerszten et al (2010) reported greater mean improvement in pain and functional scores at 6 months for nucleoplasty versus epidural steroid injections, but secondary procedure rates at 1 year were 42% (nucleoplasty) vs 68% (steroid); de Rooij et al (2020) favored anterior cervical discectomy over cervical nucleoplasty on some outcomes and was discontinued before reaching planned sample size; Chitragran et al (2012) reported pain and medication reduction versus conservative care but data presentation was limited.

Trials provide some evidence of short-term benefit but are limited for drawing definitive conclusions about long-term effectiveness and comparative effectiveness versus standard surgical approaches.

Procedures discussed in this policy — specifically laser discectomy and radiofrequency coblation (disc nucleoplasty) — are designated experimental/investigational and are not covered under this medical policy. Coverage for these services for an individual member is determined by the member's contract benefits in effect at the time of service; providers should verify benefits with Blue Cross and Blue Shield of Kansas prior to scheduling or billing.

The available evidence for laser discectomy is primarily from observational studies and case series. Because of the variable natural history of back pain and the potential for placebo effects, these observational data are insufficient to permit conclusions about the procedure's effects on health outcomes.

Earlier iterations of this policy explicitly stated that both laser discectomy and radiofrequency coblation (disc nucleoplasty) were considered experimental/investigational. The policy text has been updated over time, but the historical policy record (including revisions and rationale) reflects that these techniques have long been treated as investigational.

Given the limited observational evidence base for decompression using laser energy and the documented possibility of placebo effects in this area, the literature does not demonstrate sufficient evidence that percutaneous decompression with laser energy improves health outcomes; therefore the procedure lacks adequate evidence to support coverage as medically necessary.

The inclusion or exclusion of procedure, diagnosis, or device codes in the coding section is provided for informational purposes only and does not, by itself, constitute or imply member coverage. Determinations of medical necessity and coverage depend on whether the procedure is performed in accordance with the policy criteria and on the member's contract benefits in effect at the time of service.

Coding and Regulatory Identifiers

FDA product codes mentionedmixed

GEX	FDA product code for laser devices (percutaneous discectomy indications)
GEI	FDA product code for Perc-D SpineWand / coblation devices

Procedure codes mentionedCPT

62287	Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, any method utilizing needle based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with discography and/or epidural injection(s) at the treated level(s), when performed, single or multiple levels, lumbar.
77002	Fluoroscopic guidance for needle placement (e.g., biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure).
S2348	Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar

Conservative treatment duration noted in device indications (e.g., >= 12 weeks)

Conservative treatment duration>= 12 weeks

Source of thresholdIndication described in FDA summaries for percutaneous laser disc decompression (Trimedyne summary)

Typical prior therapies referencedConservative management such as physical therapy and medication; epidural steroid injection noted as comparator

What Providers Must Do

Note

Verify member benefits

Coverage is determined by the member's contract benefits in effect at the time of service. Verify eligibility and benefit coverage with Blue Cross and Blue Shield of Kansas Customer Service prior to scheduling or performing procedures.

Refer to member contract for coverage determination
Contact BCBSKS Customer Service to verify eligibility and benefits

Prior Authorization

Prior authorization — contact payer

Prior authorization may be required. Providers should contact Blue Cross and Blue Shield of Kansas (BCBSKS) for prior authorization requirements and any questions about coverage before performing the procedure.

Contact BCBSKS Customer Service or professional/institutional relations for prior authorization and coverage inquiries

Clinical Background

Discogenic low back pain refers to low back pain without radicular findings in the presence of radiologic degenerative disc disease. Minimally invasive percutaneous techniques such as laser discectomy (needle or catheter insertion into the disc nucleus with directed laser vaporization under fluoroscopic guidance) and disc nucleoplasty / radiofrequency coblation (use of bipolar radiofrequency energy to ablate nucleus material) are intended to reduce disc volume and relieve focal nerve compression. Typical management begins with conservative therapies (e.g., physical therapy, medications, epidural steroid injection), and these percutaneous procedures have been evaluated as alternatives to continued conservative care or to more invasive discectomy. The current evidence does not establish consistent long-term benefit for laser decompression, and randomized trial data for nucleoplasty are limited and have methodological constraints.

Procedure and Outcome Measure Definitions

Laser discectomy — definition and brief procedure description

DefinitionInsertion of a needle or catheter into the disc nucleus with delivery of a laser beam to vaporize nucleus tissue under fluoroscopic guidance.

Procedure intentPercutaneous decompression of the intervertebral disc to reduce disc volume and relieve nerve compression for discogenic pain or radiculopathy.

GuidancePerformed under fluoroscopic guidance as a minimally invasive technique.

Disc nucleoplasty / Radiofrequency coblation — definition summary

DefinitionUse of bipolar radiofrequency energy in an electrically conductive fluid to generate a high-density plasma field that ablates disc tissue via a probe (coblation).

Device/probeProcedure is accomplished with a probe mounted to a radiofrequency coblation source to perform controlled, localized ablation.

Policy Summary

PayerBlue Cross Blue Shield - Kansas

PolicyDecompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency-Coblation (Nucleoplasty)

Policy CodePolicy N/A

Change TypeNo material change

Effective DateFebruary 8, 2010

Next Review DateN/A

Key ActionVerify member benefits with BCBSKS Customer Service prior to service to confirm coverage under the member's contract.

SourceLink

On This Page

Billing Rule

Procedure coding and requirement

The procedure codes listed are informational only. Inclusion or exclusion of codes does not guarantee coverage. Codes are medically necessary ONLY when the procedure is performed in accordance with the Policy section of this document.

62287 — Decompression procedure, percutaneous, of nucleus pulposus (needle-based)
77002 — Fluoroscopic guidance for needle placement (add-on)
S2348 — Decompression procedure, percutaneous, using radiofrequency energy

Denial Risk

Experimental / Investigational designation

Laser discectomy and radiofrequency coblation (disc nucleoplasty) are considered experimental/investigational for disc decompression and treatment of associated pain. Coverage for these procedures should be determined per the member's contract.

Designated experimental/investigational — coverage determined by member contract benefits

Note

FDA device indication notes

FDA-cleared device summaries note indications that generally include symptoms and imaging consistent with a target disc and failure to respond to a period of conservative therapy (e.g., symptoms unresponsive to 12 weeks of conservative treatment). Device clearances are for specific laser systems and list intended uses related to percutaneous discectomy/decompression.

FDA summaries reference 12 weeks of failed conservative therapy as part of device indications
Trimedyne and other laser systems cleared via 510(k) for percutaneous disc procedures (product code GEX)

Documentation Required

Supporting trial documentation and prior therapy

Clinical trials and supporting documentation commonly required or referenced in the literature included prior conservative therapies and described baseline characteristics and prior treatments. Trials reported whether patients had failed or previously received epidural steroid injections or other conservative management before enrollment.

Gerszten RCT: all patients had previously had an epidural steroid injection within 3 weeks to 6 months with variable relief
Chitragran RCT and other trials reported prior conservative care in enrolled populations

Step Therapy

Conservative therapy precedes invasive options

Conservative management (physical therapy, medication management) and epidural steroid injections are typical initial therapies and should precede consideration of invasive procedures such as nucleoplasty or laser discectomy.

Conservative therapy (physical therapy, medications) is typical first-line care
Epidural steroid injection is a commonly used nonoperative comparator prior to invasive interventions

Documentation Required

Prior conservative therapy observed in studies

Prior conservative therapy was required or observed in key trials. For example, the Gerszten randomized trial enrolled patients who had prior epidural steroid injections without sustained relief; other trials compared nucleoplasty to conservative therapy or to epidural steroid injections.

Gerszten RCT required prior epidural steroid injection (3 weeks–6 months)
Trials compared nucleoplasty with conservative therapy or epidural steroid injections

Proposed advantageControlled and highly localized ablation with minimal damage to surrounding tissue.

Disc nucleoplasty (additional definition/context)

Clinical purposePercutaneous decompression of the intervertebral disc using radiofrequency coblation intended to treat discogenic back pain or radiculopathy.

Therapy framingConsidered an alternative to or potential improvement on existing therapies for discogenic pain.

Intervention nameReferred to in the document as disc nucleoplasty with radiofrequency coblation.

Laser discectomy (alternate definition entries)

MechanismPercutaneous decompression using laser energy directed into the disc nucleus to vaporize tissue and reduce disc volume.

Indications notedEvaluated for treatment of discogenic back pain; FDA-cleared laser device summaries reference percutaneous discectomy indications.

ApproachMinimally invasive technique performed under fluoroscopy with needle or catheter-based delivery.

VAS — Visual Analog Scale definition

DefinitionVisual Analog Scale (VAS): a measure of pain intensity used across trials to assess arm and neck pain; reported as numeric scores (e.g., baseline and follow-up values).

Use in trialsUsed in randomized controlled trials (e.g., de Rooij et al.) to measure arm and neck pain intensity at multiple time points.

ReportingPresented as mean scores with confidence intervals for baseline and follow-up assessments (e.g., 1 week, 3 months, 12 months).

Disability indices — Neck Disability Index and Oswestry Disability Index definitions

Neck Disability Index (NDI)Validated functional outcome measure used to assess disability due to neck pain; reported in trials (e.g., de Rooij et al.) at baseline and follow-up.

Oswestry Disability Index (ODI)Validated functional outcome measure used to assess disability related to lumbar spine conditions; used in studies of lumbar procedures.

Role in outcomesDisability indices are used alongside pain measures (VAS) and satisfaction scales to evaluate functional outcomes after nucleoplasty or discectomy.